Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 July 2024 : Clinical Research  

Cystatin SN (CST1) Is a Poor Independent Prognostic Biomarker for Gastrointestinal Diffuse Large B-Cell Lymphoma

Jie Wang1ABCDEFG*, Ming Yang2CD, Sheng Chen2CEF, Hongbo Zhu1AB, Zhirong Zhang1CD

DOI: 10.12659/MSM.943551

Med Sci Monit 2024; 30:e943551

Figure 3 Correlation between sex, age, tumor diameter, macroscopic type, lesion number, tumor site, post-operational chemotherapy, and overall survival (OS) ratesPatient’s gender (A), age (B), tumor diameter (C), macroscopic type (D), lesion number (E), tumor site (F), and post-operational chemotherapy (G) had no significant correlation with OS. The survival curves of different subgroups were plotted by the Kaplan-Meier method, and statistical significance was analyzed by the log-rank test. SPSS 22.0 and Adobe Illustrator CS5 were used to generate this figure.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750